Structural microenvironment of bone marrow stem cells

骨髓干细胞的结构微环境

基本信息

项目摘要

DESCRIPTION (provided by applicant): The definition of adult stem cell niches in the bone marrow (BM) and their regulation by extrinsic factors is a top research priority in tissue engineering and skeletal regenerative medicine, as well as a critical aspect of hematopoietic function and its reconstitution after marrow ablation therapy. Unlike the wealth of information regarding the cell types, cell-cell interactions and soluble signals that specify functionally discrete BM microenvironments, significantly less is known about the role of the extracellular matrix (ECM) in niche function to the detriment of developing more effective stem cell-based therapies. Our preliminary findings are the first to indicate involvement of fibrillin-1, a unique ECM protein that regulates the spatial organization and physical properties of tissues as well as the bioavailability of endogenous (local) TGF¿ family signals. This discovery raises the exciting possibility that a structural component of the marrow matrix controls the production of bone, blood and immune cells by determining the physical microenvironment of resident stem cells and by coordinating regulatory signals within it. Fibrillin-1 is the mutated protein in Marfan syndrome (MFS), whose pleiotropic manifestations include progressive bone loss (osteopenia). We previously demonstrated that osteopenia in MFS mice reflects perturbed bone remodeling due to impaired calibration of local anabolic and catabolic signals. Ongoing investigations have implied that fibrillin-1 is an essential component of the BM microenvironment that specifies the performance of mesenchymal stem cells (MSC) and hematopoietic stem cells (HSC). The goal of this high risk/high reward R21 application is to answer the following two questions: (a) What are the phenotypic consequences of fibrillin-1 deficiency for BM-based osteogenesis and hematopoiesis? ; (b) Does fibrillin-1 coordinate MSC-supported HSC performance? Accordingly, we propose to: (Aim 1) Characterize impaired MSC activity and bone loss progression in mice lacking fibrillin-1 in the appendicular skeleton and to provide a full account of hematopoietic abnormalities in these mutant animals; and (Aim 2) Validate the role of fibrillin-1 in coordinating MSC-supported HSC differentiation using mice with conditional Fbn1 inactivation in a specific stromal cells population. By demonstrating that fibrillin-1 is an indispensable functional component of BM niches, the experiments will establish the basis for future interrogation of the mechanism mediating fibrillin-1 regulation of marrow niches; and by implicating fibrillin-1 in immune system function, they may also lead to a radically new understanding of the cellular events responsible for aortic disease progression in MFS with unanticipated opportunities for therapy. Overall, this highly innovative proposal is expected to yield novel insights into age-related bone loss, advance fundamental knowledge of stem cell biology, impact a variety of translational applications in regenerative medicine, and perhaps improve the clinical management of life- threatening aortic manifestations in MFS.
描述(通过应用提供):骨髓(BM)中成年干细胞生态位的定义及其对外部因素的调节是组织工程和骨骼再生医学的最佳研究优先级,以及造血功能的关键方面及其在玛格育育治疗后重新结束的关键方面。与有关细胞类型的丰富信息,细胞 - 细胞相互作用和实体信号的丰富信息不同,在功能上具有离散的BM微环境,对细胞外基质(ECM)在利基功能中的作用的了解明显较小,以确定开发更有效的干细胞疗法。我们的初步发现是第一个表明Fibrillin-1的参与,Fibrillin-1是一种独特的ECM蛋白,可调节组织的空间组织和物理性质以及内源性(局部)TGF tgfqu的生物利用度。这一发现增加了令人兴奋的可能性,即通过确定居民干细胞的物理微环境以及其中的配位调节信号,骨髓基质的结构成分控制骨,血液和免疫细胞的产生。 Fibrillin-1是Marfan综合征(MFS)中突变的蛋白质,其多效性表现包括进行性骨质流失(骨质骨减少症)。我们先前证明,MFS小鼠中的骨质减少症反映出由于局部合成代谢和分解代谢信号的校准受损而导致的骨骼重塑。正在进行的研究表明,Fibrillin-1是BM微环境的重要组成部分,它指定了间充质干细胞(MSC)和造血干细胞(HSC)的性能。这种高风险/高奖励R21应用的目的是回答以下两个问题:(a)纤维蛋白-1缺乏症对基于BM的成骨和造血的表型后果是什么? (b)纤维蛋白-1是否协调MSC支持的HSC性能?根据,我们建议:( AIM 1)表征阑尾骨骼中缺乏纤维蛋白-1的小鼠MSC活性和骨质流失进展的表征,并提供了这些突变动物中造血异常的完整说明; (目标2)验证纤维蛋白-1在协调中的作用 在特定基质细胞种群中,使用小鼠与有条件的FBN1失活的小鼠相支持的HSC分化。通过证明Fibrillin-1是BM壁ches的必不可少的功能成分,实验将为介导骨髓壁ches的Fibrillin-1调节机制的未来询问建立基础。通过隐式纤维素-1在免疫系统功能中,它们也可能导致对导致主动脉疾病进展的细胞事件的根本性理解,并具有意外的治疗机会。总体而言,这一高度创新的提案有望产生对与年龄相关的骨质流失,干细胞生物学的提前基本知识的新见解,影响再生医学中的各种翻译应用,并可能改善对MFS中主动脉症的临床管理的临床管理。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

Francesco B Ramire...的其他基金

Characterization of Altered Mechanosensing in Mouse Models of ECM-induced TAA
ECM 诱导的 TAA 小鼠模型中机械传感改变的表征
  • 批准号:
    10378124
    10378124
  • 财政年份:
    2018
  • 资助金额:
    $ 18.01万
    $ 18.01万
  • 项目类别:
Tendon-dependent Control of Longitudinal Bone Growth
纵向骨生长的肌腱依赖性控制
  • 批准号:
    9975714
    9975714
  • 财政年份:
    2016
  • 资助金额:
    $ 18.01万
    $ 18.01万
  • 项目类别:
Consortium for Translational Research in Marfan Syndrome
马凡氏综合症转化研究联盟
  • 批准号:
    8724113
    8724113
  • 财政年份:
    2013
  • 资助金额:
    $ 18.01万
    $ 18.01万
  • 项目类别:
Structural microenvironment of bone marrow stem cells
骨髓干细胞的结构微环境
  • 批准号:
    8564162
    8564162
  • 财政年份:
    2013
  • 资助金额:
    $ 18.01万
    $ 18.01万
  • 项目类别:
Consortium for Translational Research in Marfan Syndrome
马凡氏综合症转化研究联盟
  • 批准号:
    8776626
    8776626
  • 财政年份:
    2013
  • 资助金额:
    $ 18.01万
    $ 18.01万
  • 项目类别:
ARCHITECTURAL MICROFIBRILS IN BONE PHYSIOLOGY
骨生理学中的结构微纤维
  • 批准号:
    7900628
    7900628
  • 财政年份:
    2009
  • 资助金额:
    $ 18.01万
    $ 18.01万
  • 项目类别:
Experimental models of scleroderma pathogenesis
硬皮病发病机制的实验模型
  • 批准号:
    7681528
    7681528
  • 财政年份:
    2008
  • 资助金额:
    $ 18.01万
    $ 18.01万
  • 项目类别:
Experimental models of scleroderma pathogenesis
硬皮病发病机制的实验模型
  • 批准号:
    7535275
    7535275
  • 财政年份:
    2008
  • 资助金额:
    $ 18.01万
    $ 18.01万
  • 项目类别:
Microfibrils in Vascular Morphogenesis and Disease
微原纤维在血管形态发生和疾病中的作用
  • 批准号:
    7460909
    7460909
  • 财政年份:
    2007
  • 资助金额:
    $ 18.01万
    $ 18.01万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    7503644
    7503644
  • 财政年份:
    2007
  • 资助金额:
    $ 18.01万
    $ 18.01万
  • 项目类别:

相似国自然基金

签字注册会计师动态配置问题研究:基于临阵换师视角
  • 批准号:
    72362023
  • 批准年份:
    2023
  • 资助金额:
    28 万元
  • 项目类别:
    地区科学基金项目
全生命周期视域的会计师事务所分所一体化治理与审计风险控制研究
  • 批准号:
    72372064
  • 批准年份:
    2023
  • 资助金额:
    40 万元
  • 项目类别:
    面上项目
会计师事务所数字化能力构建:动机、经济后果及作用机制
  • 批准号:
    72372028
  • 批准年份:
    2023
  • 资助金额:
    42.00 万元
  • 项目类别:
    面上项目
会计师事务所薪酬激励机制:理论框架、激励效应检验与优化重构
  • 批准号:
    72362001
  • 批准年份:
    2023
  • 资助金额:
    28.00 万元
  • 项目类别:
    地区科学基金项目
环境治理目标下的公司财务、会计和审计行为研究
  • 批准号:
    72332002
  • 批准年份:
    2023
  • 资助金额:
    165.00 万元
  • 项目类别:
    重点项目

相似海外基金

Elucidation of the mechanism of disease of VEXAS Syndrome
阐明VEXAS综合征的发病机制
  • 批准号:
    10752251
    10752251
  • 财政年份:
    2023
  • 资助金额:
    $ 18.01万
    $ 18.01万
  • 项目类别:
Targeting RHNO1 in Ovarian Cancer
靶向 RHNO1 治疗卵巢癌
  • 批准号:
    10648755
    10648755
  • 财政年份:
    2023
  • 资助金额:
    $ 18.01万
    $ 18.01万
  • 项目类别:
Effect of Perinatal Exposure to Metals on Lung Function Trajectories and Mitochondrial DNA Heteroplasmy from Childhood to Adolescence
围产期金属暴露对儿童期至青春期肺功能轨迹和线粒体 DNA 异质性的影响
  • 批准号:
    10446235
    10446235
  • 财政年份:
    2022
  • 资助金额:
    $ 18.01万
    $ 18.01万
  • 项目类别:
Effect of Perinatal Exposure to Metals on Lung Function Trajectories and Mitochondrial DNA Heteroplasmy from Childhood to Adolescence
围产期金属暴露对儿童期至青春期肺功能轨迹和线粒体 DNA 异质性的影响
  • 批准号:
    10624291
    10624291
  • 财政年份:
    2022
  • 资助金额:
    $ 18.01万
    $ 18.01万
  • 项目类别:
Determining the Efficacy of Corneal Cross-Linking Protocols using Brillouin Microscopy
使用布里渊显微镜确定角膜交联方案的功效
  • 批准号:
    10642876
    10642876
  • 财政年份:
    2022
  • 资助金额:
    $ 18.01万
    $ 18.01万
  • 项目类别: